Abstract
The antimicrobial activity of cefmenoxime was compared with those of cefamandole, cefoperazone, cefotaxime, cephalothin, and moxalactam. In general, the activity of cefmenoxime was equivalent to those of the other cephalosporins. Cefmenoxime appears to be a potent antimicrobial agent against most gram-negative microorganisms other than Pseudomonas aeruginosa and Acinetobacter spp.
Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ahonkhai V. I., Cherubin C. E., Shulman M. A., Bancroft U. Comparative in vitro activities of cefmenoxime (SCE-1365) and newer cephalosporin derivatives of clinical utility. Antimicrob Agents Chemother. 1982 Jun;21(6):999–1002. doi: 10.1128/aac.21.6.999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fuchs P. C., Jones R. N., Thornsberry C., Barry A. L., Gerlach E. H., Sommers H. M. Cefmenoxime (SCE-1365), a new cephalosporin: in vitro activity, comparison with other antimicrobial agents, beta-lactamase stability, and disk diffusion testing with tentative interpretive criteria. Antimicrob Agents Chemother. 1981 Dec;20(6):747–759. doi: 10.1128/aac.20.6.747. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Neu H. C., Labthavikul P. In vitro activity and beta-lactamase stability of cefmenoxime. Antimicrob Agents Chemother. 1982 Aug;22(2):316–322. doi: 10.1128/aac.22.2.316. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stamm J. M., Girolami R. L., Shipkowitz N. L., Bower R. R. Antimicrobial activity of cefmenoxime (SCE-1365). Antimicrob Agents Chemother. 1981 Mar;19(3):454–460. doi: 10.1128/aac.19.3.454. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tsuchiya K., Kondo M., Kida M., Nakao M., Iwahi T., Nishi T., Noji Y., Takeuchi M., Nozaki Y. Cefmenoxime (SCE-1365), a novel broad-spectrum cephalosporin: in vitro and in vivo antibacterial activities. Antimicrob Agents Chemother. 1981 Jan;19(1):56–65. doi: 10.1128/aac.19.1.56. [DOI] [PMC free article] [PubMed] [Google Scholar]
